Sökning: "Chronic venous disease"

Visar resultat 11 - 15 av 35 avhandlingar innehållade orden Chronic venous disease.

  1. 11. Epidemiological perspective of chronic immune thrombocytopenia

    Författare :Charlotta Ekstrand; Karolinska Institutet; Karolinska Institutet; []
    Nyckelord :;

    Sammanfattning : This thesis deals with different aspects of immune thrombocytopenia disease (ITP), what happens before diagnosis, characteristics of patients at treatment start and outcomes potentially related to the disease and treatment, such as thrombosis and cancer. In study one we investigate the risk of infections prior to the diagnosis of ITP. LÄS MER

  3. 12. Immune mechanisms in atherosclerotic vascular disease

    Författare :Jasmina Cvetkovic; Karolinska Institutet; Karolinska Institutet; []
    Nyckelord :Atherosclerosis; rheumatoid arthritis; stroke; autoantibodies; pro-inflammatory cytokines;

    Sammanfattning : Atherosclerosis has been categorized as an inflammatory disorder, with similar chronic inflammatory conditions found in rheumatoid arthritis. It entails an unregulated accumulation of lipids in the vessel wall, which leads to the development of cardiovascular diseases. LÄS MER

  4. 13. Investigation of hepatocyte signaling pathways in chronic kidney disease : clinical and experimental studies

    Författare :Meng Li; Karolinska Institutet; Karolinska Institutet; []
    Nyckelord :;

    Sammanfattning : Chronic kidney disease (CKD) is defined as a loss of renal function from any cause and lasting for more than three months. The CKD phenotype is similar across multiple etiologies, suggesting that renal damage itself is a dominant factor. LÄS MER

  5. 14. Dialysis initiation and clinical outcomes in chronic kidney disease : role of education and biomarkers

    Författare :Anna Machowska; Karolinska Institutet; Karolinska Institutet; []
    Nyckelord :;

    Sammanfattning : For patients with chronic kidney disease (CKD) who develop kidney failure, renal replacement therapy (RRT) with kidney transplantation is the best treatment option. But if this is not possible due to lack of organs or medical factors, dialysis initiation with haemodialysis (HD) or peritoneal dialysis (PD) is required. LÄS MER

  7. 15. Endogenous tissue-type plasminogen activator andendothelial function in vivo. A clinical perspective

    Författare :Thorarinn Gudnason; Göteborgs universitet; []
    Nyckelord :tissue-type plasminogen activator; endothelial function; age; vasodilation; chronic heart failure; coronary artery disease; local regulation; perfused-forearm model;

    Sammanfattning : Endogenous fibrinolysis is initiated by the glycoprotein tissue-type plasminogen activator (tPA), which is released from the vascular endothelium. Plasminogen activator inhibitor type 1 (PAI-1) is the main inhibitor of tPA. LÄS MER